CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009
Table 2
Median CD4 cell count (cells/mm3) at HIV diagnosis* by demographic characteristics and study period during which HIV diagnosis occurred, the HIV Outpatient Study, 2000–2009. Table presents only strata including at least 100 patients in the study.
2000-2001 ()
2002-2003 ()
2004-2005 ()
2006-2007 ()
2008-2009 ()
P value for trend†
All years ()
Overall, median (interquartile range)
284 (99–438)
298 (71–523)
288 (110–501)
320 (139–517)
314 (90–502)
0.13
299 (100–498)
Overall, mean (95% confidence interval)
312 (277–347)
346 (306–386)
341 (302–380)
354 (312–396)
353 (303–402)
—
339 (321–358)
By gender
Male ()
272
320
293
355
305
0.34
304
Female ()
287
258
283
222
374
0.22
286
By race/ethnicity
Non-Hispanic white ()
362
333
316
383
352
0.69
348
Non-Hispanic black ()
243
272
282
264
276
0.60
271
By HIV infection risk group
MSM ()
351
375
308
386
336
0.80
351
Heterosexual ()
209
247
229
288
293
0.09
247
By medical insurer
Privately insured ()
284
336
301
343
328
0.38
310
Publicly insured ()
230
267
234
213
294
0.27
260
By type of facility
Public ()
208
225
277
212
276
0.10
247
Private ()
331
337
310
343
352
0.32
330
*For inclusion in this analysis, patients must have had a CD4 cell count measured within 1 month prior to or up to 3 months after the date of HIV diagnosis while remaining antiretroviral-naïve. †By Jonckheere-Terpstra nonparametric test for continuous variables. ‡Differences in CD4 counts by race/ethnicity, HIV infection risk group, insurance, and type of facility were all statistically significant (nonparametric Wilcoxon rank sum test ).
